Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06269536 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stress-reducing Intervention in Urothelial Carcinoma

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The aim of this interventional study is to test the heart-rate variability biofeedback intervention (HRV BI) in patients with muscle-infiltrating bladder carcinoma (MIBC) treated with chemotherapy based on cisplatin in neoadjuvant setting followed by local therapy (standard of care, SOC) compared to SOC alone.
Trial Details
NCT Number NCT06269536
Lead Sponsor Comenius University
Conditions
(from sponsor)		 Bladder Cancer
Related terms Inflammation, Sleep Initiation and Maintenance Disorders, Urinary Bladder Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov